| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |